AzTrials
AzTrials

Parkinson's Disease (PD)NCT07641569

Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease

A study testing Single Task Exercise Training, Motor-Motor Dual Task Exercise Training and Cognitive-Motor Dual Task Exercise Training in people with Parkinson's Disease (PD), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are: Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in… Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Parkinson's Disease (PD)
What is being tested?
Single Task Exercise Training, Motor-Motor Dual Task Exercise Training and Cognitive-Motor Dual Task Exercise Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jun 2026to 16 Oct 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Having been diagnosed with Parkinson's disease by a neurologist according to the UK Brain Bank criteria.
  • Being in stages 1-3 according to the Hoehn-Yahr Scale.

Who cannot join

  • Presence of a neurological disease other than Parkinson's disease
  • Cognitive impairment (Standardized Mini Mental Test score less than 24)
  • Having undergone deep brain stimulation surgery
  • Having a visual, auditory, or perceptual problem
  • Having any orthopedic, rheumatological, or other condition that may affect walking and balance.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gülhane Faculty of Physiotherapy and Rehabilitation

    Ankara, Keçiören, 06010

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease

The aim of this study is to compare the effectiveness of motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease.The main questions it aims to answer are:

  • Whether there is a difference between motor-motor dual-task training and cognitive-motor dual-task training in patients with Parkinson's disease in terms of their effects on motor symptoms, balance, gait, functional mobility, activities of daily living, dual-task activities, cognitive functions, and balance confidence.
Read more

Researchers will compare single-task training, motor-motor dual task training and cogvitive-motor dual task training.

Participants will:

  • Receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks.
  • Participate in assessments at the study clinic before and after exercise training.
Being tested
Single Task Exercise Training, Motor-Motor Dual Task Exercise Training, Cognitive-Motor Dual Task Exercise Training
Keywords
Parkinson's Disease, Dual Task Training, Motor-Motor, Cognitive-Motor
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Single Task Exercise TrainingOther

    Single task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises with a 5-minute rest in between, and then a 5-minute cool-down period.

  • Motor-Motor Dual Task Exercise TrainingOther

    Motor-motor dual task balance and walking exercises. Motor-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with upper extremity motor tasks with a 5-minute rest in between, and then a 5-minute cool-down period.

  • Cognitive-Motor Dual Task Exercise TrainingOther

    Cognitive-motor dual task balance and walking exercises. Cognitive-motor dual task balance and walking exercises. 5-minute warm-up period, followed by 15 minutes of balance exercises and 15 minutes of walking exercises concurrently performed with cognitive tasks with a 5-minute rest in between, and then a 5-minute cool-down period.

Study groups in NCT07641569
Study groupRoleWhat they receive
Single Task TrainingActive comparatorSingle task balance and walking training
Receives: Other: Single Task Exercise Training
Motor-Motor Dual Task TrainingExperimentalMotor-motor dual task balance and walking training
Receives: Other: Motor-Motor Dual Task Exercise Training
Cognitive-Motor Dual Task TrainingExperimentalCognitive-motor dual task balance and walking training
Receives: Other: Cognitive-Motor Dual Task Exercise Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3

    UPDRS is a reliable and valid scale that assesses cognitive skills, mood, daily living activities, motor skills, motor fluctuations, dyskinesias and autonomic dysfunction and is widely used in clinical studies and research in Parkinson's disease. The motor symptoms section, which is the third section of this scale, will be used.

    Measured: From enrollment to the end of training at 6 weeks

  2. Hoehn & Yahr Scale

    It is a staging system that provides information quickly in determining the severity and symptoms of Parkinson's disease.

    Measured: From enrollment to the end of treatment at 6 weeks

  3. Single-Leg Stance Test

    This is a test method used to assess static balance. The patient's preferred foot is raised without touching the supporting leg, and initially, the eyes are open. The eyes are fixed towards the head, and the patient is expected to maintain their balance for 60 seconds. The time the participant maintains their balance is recorded.

    Measured: From enrollment to the end of treatment at 6 weeks

  4. Functional Reach Test

    This test is designed to assess dynamic balance. In the test, the participant is positioned sideways next to a wall, with their torso upright, the shoulder on the wall flexed to 90°, and the elbow fully extended. The participant is then asked to make a fist with the same arm, and the position of the third metacarpal head is marked on the wall. The participant reaches forward with their knees fully extended; the position of the third metacarpal head is marked again, and the participant returns to the starting position. The difference between the two marks is measured with a tape measure.

    Measured: From enrollment to the end of treatment at 6 weeks

  5. 10 Meter Walking Test

    Participants are asked to walk at normal walking speed for a distance of 10 meters and the time is recorded.

    Measured: From enrollment to the end of treatment at 6 weeks

  6. Motor-Motor Dual Task Cost of Walking

    To assess the motor-motor dual-task cost of walking, patients will perform the 10-meter walk test once as a single task and once while holding an empty plate on a tray in their hands. The dual-task cost will be calculated as a percentage using the following formula:

    [(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]

    Measured: From enrollment to the end of treatment at 6 weeks

  7. Cognitive-Motor Dual Task Cost of Walking

    To assess cognitive-motor dual-task cost of walking, patients will perform the 10-Meter Walk Test once as a single task and once as a dual-task test, counting backwards in increments of 7 from a three-digit number greater than 300. Dual-task cost will be calculated as a percentage using the following formula:

    [(Dual-task performance - Single-task performance)/ (Single-task performance) x 100]

    Measured: From enrollment to the end of treatment at 6 weeks

  8. Timed Up and Go Test

    This test is used to assess functional mobility levels. The test involves using a standard chair with the individual's knees flexed at 90° and their backrest against it. The individual is asked to stand up from the chair, walk 3 meters, turn around, and then walk back to the chair and sit down. The test begins with the command "walk," and the test duration is measured with a stopwatch and recorded in seconds.

    Measured: From enrollment to the end of treatment at 6 weeks

  9. Unified Parkinson's Disease Rating Scale (UPDRS) - PART 2

    It consists of thirteen items. The assessment is based on anamnesis information regarding how the patient functions in various activities. The presence of sensory complaints that may be related to tremor and parkinsonism is also included in this section as they can affect daily living activities. Each item is evaluated using a scoring system between '0' and '4'.

    Measured: From enrollment to the end of treatment at 6 weeks

  10. Dual Task Questionnaire

    This test is used to assess the challenges encountered in daily tasks involving dual work. It consists of 10 questions and is administered via face-to-face interview. Each question is scored between 0 and 4. A score of "4" indicates frequent challenges, while a score of "0" indicates no challenges.

    Measured: From enrollment to the end of treatment at 6 weeks

  11. Trail Making Test

    It is used to assess executive functions and attention. The test consists of two parts, A and B. In part A, the individual is asked to combine numbers from 1 to 25, and the completion time is recorded. In part B, the individual completes a sequence where each number corresponds to a letter, and the completion time is recorded.

    Measured: From enrollment to the end of treatment at 6 weeks

  12. Activity-Specific Balance Confidence Scale

    This is a commonly used scale for assessing balance confidence. The scale evaluates whether individuals believe they can perform daily living activities without losing their balance or becoming unsteady. It consists of sixteen items. Each item is scored between a minimum of "0" (unconfident) and a maximum of "100" (completely confident). The base score is calculated by dividing the total score by 16. Higher values indicate that the person feels good about their balance, while lower values are associated with an increased risk of falls.

    Measured: From enrollment to the end of treatment at 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2026
  2. Study start15 Jun 2026
  3. Primary completion16 Oct 2026
  4. Study completion16 Oct 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07641569
Sponsor's protocol ID
2026-152
Status last verified
Oct 2026
First submitted
6 Jun 2026
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Single Task Exercise Training, Motor-Motor Dual Task Exercise Training and Cognitive-Motor Dual Task Exercise Training in people with Parkinson's Disease (PD), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Unified Parkinson's Disease Rating Scale (UPDRS) - PART 3 (time frame: From enrollment to the end of training at 6 weeks). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in